Table 1.
Patients’ demographic and clinical characteristics
| Variable | Patients: n (%)a |
|---|---|
| Gender | |
| Male | 274 (49) |
| Female | 281 (51) |
| Age | |
| ≤ 30 | 120 (21.6) |
| 31–40 | 94 (16.9) |
| 41–50 | 122 (22) |
| > 50 | 219 (39.5) |
| Overall prescribed drugsb | |
| ≤ 5 | 111 (20) |
| 6–7 | 114 (20.5) |
| 8–9 | 131 (23.6) |
| ≥ 10 | 199 (35.9) |
| Diagnoses | |
| Breast cancer | 86 (15.5) |
| Non hodgkin lymphoma | 84 (15.1) |
| Gastrointestinal cancer | 71 (12.8) |
| Gynecologic cancer | 33 (5.9) |
| Acute lymphoblastic leukemia | 29 (5.2) |
| Genitourinary cancer | 23 (4.1) |
| Hodgkin lymphoma | 17 (3.1) |
| Chronic lymphocytic leukemia | 15 (2.7) |
| Musculoskeletal cancer | 14 (2.5) |
| Acute mylogenous leukemia | 11 (2) |
| Ovarian cancer | 11 (2) |
| Colorectal carcinoma | 11 (2) |
| Lung cancer | 10 (1.8) |
| Head and neck cancer | 8 (1.4) |
| Comorbidities | |
| Diabetes mellitus | 27 (4.9) |
| Hypertension | 23 (4.1) |
| Hepatitis B | 3 (0.5) |
| Hepatitis C | 3 (0.5) |
aPercentage calculated in total number of patients i.e., 555
bOverall prescribed medications mean QT prolonging medications as well as other medications